Comparison of Sirolimus Versus Paclitaxel Eluting Stents for Treatment of Coronary In-Stent Restenosis

American Journal of Cardiology

Volumn 97, Issue 8, 2006, Pages 1182-1187

  Airoldi, Flavio ^a   Briguori, Carlo ^a   Iakovou, Ioannis ^b   Stankovic, Goran ^c   Biondi Zoccai, Giuseppe ^a   Carlino, Mauro ^a   Chieffo, Alaide ^a   Montorfano, Matteo ^a   Cosgrave, John ^b   Michev, Iassen ^a   Rogacka, Renata ^a   Sangiorgi, Giuseppe Massimo ^b   Colombo, Antonio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM Centro Cuore   (Italy)

^c San Raf faele Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DATABASES; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PACLITAXEL; RECURRENCE; RISK FACTORS; SIROLIMUS; STENTS;

EID: 33645735005     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.034     Document Type: Article

References (30)

1. Al Suwaidi J., Berger P.B., and Holmes D.R. Coronary artery stents. JAMA 284 (2000) 1828-1836
2. Goldberg S.L., Loussararian A., De Gregorio J., Di Mario C., Albiero R., and Colombo A. Predictors of diffuse and aggressive intra-stent restenosis. J Am Coll Cardiol 37 (2001) 1019-1025
3. Eltchaninoff H., Koning R., Tron C., Gupta V., and Cribier A. Balloon angioplasty for the treatment of coronary in-stent restenosis. immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 32 (1998) 980-984
4. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., and Leon M.B. Angiographic patterns of in-stent restenosis. classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
5. Mehran R., Mintz G.S., Popma J.J., Pichard A.D., Satler L.F., Kent K.M., Griffin J., and Leon M.B. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol 78 (1996) 618-622
6. Alfonso F., Cequier A., Zueco J., Moris C., Suarez C.P., Colman T., Esplugas E., Perez-Vizcayno M.J., Fernandez C., and Macaya C. Stenting the stent. initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis. Am J Cardiol 85 (2000) 327-332
7. Adamian M., Colombo A., Briguori C., Nishida T., Marsico F., Di Mario C., Albiero R., Moussa I., and Moses J.W. Cutting balloon angioplasty for the treatment of in-stent restenosis. a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol 38 (2001) 672-679
8. vom Dahl J., Dietz U., Haager P.K., Silber S., Niccoli L., Buettner H.J., Schiele F., Thomas M., Commeau P., Ramsdale D.R., et al. Rotational atherectomy does not reduce recurrent in-stent restenosis. results of the Angioplasty versus Rotational atherectomy for Treatment of diffuse In-Stent restenosis Trial (ARTIST). Circulation 105 (2002) 583-588
9. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., and Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis. the INHIBIT randomised controlled trial. Lancet 359 (2002) 551-557
10. Radke P.W., Kaiser A., Frost C., and Sigwart U. Outcome after treatment of coronary in-stent restenosis. results from a systematic review using meta-analysis techniques. Eur Heart J 24 (2003) 266-273
11. Waksman R., Ajani A.E., White R.L., Chan R., Bass B., Pichard A.D., Satler L.F., Kent K.M., Torguson R., Deible R., Pinnow E., and Lindsay J. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 109 (2004) 340-344
12. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., Schuhlen H., Schmitt C., Dirschinger J., Schomig A., and ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. a randomized controlled trial. JAMA 293 (2005) 165-171
13. Airoldi F., Rogacka R., Briguori C., Chieffo A., Carlino M., Montorfano M., Mikhail G., Iakovou I., Michev I., Vitrella G., Albiero R., and Colombo A. Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis. Am J Cardiol 94 (2004) 1297-1300
14. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
15. Neumann F.J., Desmet W., Grube E., Brachmann J., Presbitero P., Rubartelli P., Mugge A., Di Pede F., Fullgraf D., Aengevaeren W., Spedicato L., and Popma J.J. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 111 (2005) 2107-2111
16. Degertekin M., Lemos P.A., Lee C.H., Tanabe K., Sousa J.E., Abizaid A., Regar E., Sianos G., van der Giessen W.J., de Feyter P.J., Wuelfert E., Popma J.J., and Serruys P.W. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. Eur Heart J 25 (2004) 32-38
17. Tanabe K., Serruys P.W., Grube E., Smits P.C., Selbach G., van der Giessen W.J., Staberock M., de Feyter P., Müller R., Regar E., et al. TAXUS III trial. in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 107 (2003) 559-564
18. Sousa J.E., Costa M.A., Abizaid A., Sousa A.G., Feres F., Mattos L.A., Centemero M., Maldonado G., Abizaid A.S., Pinto I., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis. a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 107 (2003) 24-27
19. Degertekin M., Regar E., Tanabe K., Smits P.C., van der Giessen W.J., Carlier S.G., de Feyter P., Vos J., Foley D.P., Ligthart J.M., Popma J.J., and Serruys P.W. Sirolimus-eluting stent for treatment of complex in-stent restenosis. the first clinical experience. J Am Coll Cardiol 41 (2003) 184-189
20. Airoldi F., Di Mario C., Stankovic G., Briguori C., Bramucci E., Reimers B., Ardissino D., Aurier E., Tavano D., and Colombo A. Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheter. Am J Cardiol 92 (2003) 725-728
21. Strauss B.H., Umans V.A., van Suylen R.J., de Feyter P.J., Marco J., Robertson G.C., Renkin J., Heyndrickx G., Vuzevski V.D., Bosman F.T., et al. Directional atherectomy for treatment of restenosis within coronary stents. clinical, angiographic and histologic results. J Am Coll Cardiol 20 (1992) 1465-1473
22. Briguori C., Condorelli G., Airoldi F., Manganelli F., Violante A., Focaccio A., Ricciardelli B., and Colombo A. Impact of microvascular complications on outcome after coronary stent implantations in patients with diabetes. J Am Coll Cardiol 45 (2005) 464-466
23. Abizaid A., Kornowski R., Mintz G.S., Hong M.K., Abizaid A.S., Mehran R., Pichard A.D., Kent K.M., Satler L.F., Wu H., Popma J.J., and Leon M.B. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32 (1998) 584-589
24. Abizaid A., Costa M.A., Centemero M., Abizaid A.S., Legrand V.M., Limet R.V., Schuler G., Mohr F.W., Lindeboom W., Sousa A.G., et al., Arterial Revascularization Therapy Study Group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients. insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104 (2001) 533-538
25. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
26. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M.E., and TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
27. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
28. Orlic D., Bonizzoni E., Stankovic G., Airoldi F., Chieffo A., Corvaja N., Sangiorgi G., Ferraro M., Briguori C., Montorfano M., Carlino M., and Colombo A. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation. immediate and mid-term results. J Am Coll Cardiol 43 (2004) 1154-1160
29. Lemos P.A., Hoye A., Goedhart D., Arampatzis C.A., Saia F., van der Giessen W.J., McFadden E., Sianos G., Smits P.C., Hofma S.H., de Feyter P.J., van Domburg R.T., and Serruys P.W. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients. an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109 (2004) 1366-1370
30. Hausleiter J., Kastrati A., Mehilli J., Vogeser M., Zohlnhofer D., Schuhlen H., Goos C., Pache J., Dotzer F., Pogatsa-Murray G., Dirschinger J., Heemann U., Schomig A., and OSIRIS Investigators. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis. the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation 110 (2004) 790-795